Results for “ ”

Entry Author Date Location
Harvard Unveils $15M Life Lab to House Biotech and Medical Startups 06/08/16 Boston
Ginkgo Gulps $100M to Build Synthetic Food, Fragrance Business 06/08/16 Boston
Boston-Israel Connection Rising: 200-Plus Firms, 9K Jobs, $9B Sales 06/08/16 Boston
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Pronutria Rebrands as Axcella Health, Forms “Nutrition” Subsidiary 06/07/16 Boston
Startups: Get Free Tickets to Influx on June 22, Thanks to NEVCA 06/06/16 Boston
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
No PhD, “No Fear”: Alice Zhang, 27, Aims Software At Neuro Diseases 06/06/16 San Francisco
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Guardant Health Maps Cautious Plans For Blood-Based Cancer Screening 06/03/16 San Francisco
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Silicon Valley Vets Aim to Shake Up Preclinical Testing With Vium 06/02/16 San Francisco
Saver Rate Ends Today for INFLUX—Grab Your Tickets Now 06/01/16 Boston
RA Capital Seeds Peanut Allergy Prevention Startup With $1.7M 06/01/16 Boston
Two Years After Paying $680M, BioMarin Shelves Duchenne Drug 05/31/16 San Francisco
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease 05/28/16 New York
Busy FDA Week Ends With Two Drug Approvals: Another Might Be on Way 05/27/16 Boston
With Recruits Coming, Precision Med Effort Pledges $142M For Biobank 05/27/16 National
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming 05/26/16 National
Minerva’s Shares Soar on Early Data for Schizophrenia Drug 05/26/16 Boston
Agenda Live For Influx—Event Welcomes Boston’s Innovation Newcomers 05/26/16 Boston
After Failed Trial, Forum CEO Dunsire Leaves, Company’s Fate Unclear 05/25/16 Boston
Spero Rolls up More Antibiotics With Vertex Deal 05/25/16 Boston
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Join GE, Watson Health, Akamai, and More at INFLUX on June 22 05/24/16 Boston
Page 3 of 288 « previous page · next page »